Brexpiprazole

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

Policy Statement

This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and follows the requirements of the American Nurses Credentialing Center's Commission on Accreditation. It is the policy of NurseCe4Less.com to ensure objectivity, transparency, and best practice for online continuing education.

Continuing Education Credit Designation

This educational activity is credited for 2.5 hours at completion of the activity. Pharmacology content is 2.5 hours.

Statement of Learning Need

Second-generation antipsychotic drugs may be overlooked by general clinicians as a treatment for depression. Brexpiprazole may be used as an adjunctive therapy along with antidepressants to treat major depressive disorder for patients diagnosed with a chronic mental illness such as schizophrenia and major depression. Clinicians need to know the indications, dosing and dosing adjustments, contraindications and potential side effects of brexpiprazole use.

Course Purpose 

To inform health clinicians of current published information relative to the basic pharmacological profile of brexpiprazole and the clinical pearls on topics that were covered in the basic pharmacological profile.

Target Audience

Advanced Practice Registered Nurses, Registered Nurses, and other Interdisciplinary Health Team Members.

Disclosures 

Dana Bartlett, RN, BSN, MSN, MA, CSPI, William Cook, PhD, Douglas Lawrence, MA, Susan DePasquale, MSN, FPMHNP-BC – all have no disclosures. There is no commercial support for this course.

Learner Feedback